Bruker BRKR
NASDAQ BRKR
$54.46 -3.91 (-6.71%)
As of: Sep 9, 2026 · 3:59 PM EDT

Bruker (BRKR) Net Income towards Common Stockholders (2010 - 2026)

Bruker's (BRKR) quarterly Net Income towards Common Stockholders came in at -$62.9 million in Q2 2026, down 927.63% on a YoY basis from $7.6 million in Q2 2025, and down 1897.14% quarter-over-quarter from $3.5 million in Q1 2026.

Analysis

Bruker (BRKR) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends

Bruker (BRKR) has reported Net Income towards Common Stockholders for 17 consecutive years, with -$62.9 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Net Income towards Common Stockholders fell 927.63% year-over-year to -$62.9 million; the trailing twelve-month figure through Jun 2026 stood at -$106.9 million (down 234.3% YoY), and the FY2025 full-year result was -$22.5 million, down 119.89% from the prior year.
  • Net Income towards Common Stockholders slipped to -$62.9 million in Q2 2026 per BRKR's latest filing, from $3.5 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $205.5 million in Q4 2023 and bottomed at -$62.9 million in Q2 2026.
  • Historically, Net Income towards Common Stockholders has averaged $41.9 million across 5 years, with a median of $45.2 million in 2022.
  • The sharpest annual moves came in 2023 and 2026: Net Income towards Common Stockholders surged 110.99% in 2023, then plunged 927.63% in 2026.
  • Over 5 years, Net Income towards Common Stockholders stood at $97.4 million in 2022, then soared by 110.99% to $205.5 million in 2023, then slumped by 93.33% to $13.7 million in 2024, then rose by 8.76% to $14.9 million in 2025, then plunged by 522.15% to -$62.9 million in 2026.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$62.9 million, $3.5 million, and $14.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Thermo Fisher Scientific 225.48 Bn 221.41 Bn 8.34 Bn 1.76 Bn
2 Danaher 144.42 Bn 140.08 Bn 3.61 Bn 870.00 Mn
3 Agilent Technologies 40.86 Bn 39.11 Bn 1.04 Bn 362.00 Mn
4 Illumina 30.97 Bn 29.80 Bn 770.00 Mn 207.00 Mn
5 Revvity 13.85 Bn 12.83 Bn 416.87 Mn 51.82 Mn
6 Bio-Techne 11.27 Bn 11.01 Bn 211.39 Mn 54.62 Mn
7 Bio-Rad Laboratories 10.11 Bn 8.49 Bn 345.80 Mn 371.40 Mn
8 Repligen 9.33 Bn 8.31 Bn 110.04 Mn 5.01 Mn
9 10x Genomics 8.77 Bn 8.21 Bn 112.50 Mn -17.93 Mn
10 Bruker 8.30 Bn 8.09 Bn 416.00 Mn -62.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -62.90 Mn
Mar 31, 2026 3.50 Mn
Dec 31, 2025 14.90 Mn
Sep 30, 2025 -62.40 Mn
Jun 30, 2025 7.60 Mn
Mar 31, 2025 17.40 Mn
Dec 31, 2024 13.70 Mn
Sep 30, 2024 40.90 Mn
Jun 30, 2024 7.60 Mn
Mar 31, 2024 50.90 Mn
Dec 31, 2023 205.50 Mn
Sep 30, 2023 88.10 Mn
Jun 30, 2023 57.10 Mn
Mar 31, 2023 76.50 Mn
Dec 31, 2022 97.40 Mn
Sep 30, 2022 88.10 Mn
Jun 30, 2022 49.50 Mn
Mar 31, 2022 61.60 Mn
Dec 31, 2021 75.70 Mn
Sep 30, 2021 87.10 Mn